Activity of ALRT 1550, a new retinoid, with interferon-γ on ovarian cancer cell lines

International Journal of Gynecological Cancer

Volumn 12, Issue 2, 2002, Pages 202-207

  Hu, W ^a   Verschraegen, C F ^a   Wu, W G ^a   Nash, M ^a   Freedman, R S ^a   Kudelka, A ^a   Kavanagh, J J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

ALRT 1550; IFN ; Ovarian neoplasm

Indexed keywords

7 (3,5 DI TERT BUTYLPHENYL) 3 METHYL 2,4,6 OCTATRIENOIC ACID; GAMMA INTERFERON; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERFERON TYPE II; OVARIAN NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOIDS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0036249614     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01084.x     Document Type: Article

References (30)

1. Systemic therapy for gynecologic cancer
2. The role of hormonal therapy in the management of ovarian cancer
3. Biology of gynecologic cancers
4. Human ovarian cancer of the surface epithelium
5. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
6. Retinoids in cancer prevention
7. Recent advances in chemoprevention of cancer
8. Retinoids and ovarian cancer
9. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide
10. Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer
11. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
12. Can fenretinide protect women against ovarian cancer?
13. A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice
14. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons
15. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells
16. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines
17. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells
18. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin
19. Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors
20. Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth
21. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids
22. Retinoids and interferon: A new promising combination?
23. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo
24. Modulation of interferon action by retinoids. Induction of murine STAT1 gene expression by retinoic acid
25. Estrogen induces retinoid receptor expression in mouse cervical epithelia
26. Biphasic action of retinoid gonadotropin receptor induction in rat granulosa cells in vitro
27. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor
28. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
29. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon- and retinoic acid combination, using a genetic approach